Compugen Ltd. (Nasdaq:CGEN) announced today that Evogene Ltd., its agricultural biotechnology subsidiary, is in the final stages of closing a $2 million private placement with a group of Israeli, European and United States investors.
Evogene is an emerging company focused on the development of "tailor-made" plants and plant "biofactories" for the improvement of crops and plant derived products. The company is unique in merging state-of-the-art molecular biology and computational technologies with the most advanced classical breeding technologies.
Compugen's agricultural biotechnology activity was initiated in 1999 as a division of Compugen with the expectation that it would be spun off as a separate company in order to allow Compugen to maintain its focus on human therapeutics and diagnostics. In January 2002, this was accomplished through the co-founding of Evogene as a majority-owned subsidiary of Compugen together with Dr. Hagai Karchi and Dr. Rafi Meissner.
Mor Amitai, Ph.D., president and chief executive officer of Compugen, said, "We have been very pleased by the progress of Evogene and are delighted that the company has been successful in raising additional funding. Under the initial agreement between the two companies, we agreed to provide financing for Evogene's expected expenditures during 2002, and granted Evogene a license to utilize our LEADS computational biology platform and other technologies in the field of agricultural biotechnology. We are pleased to see that Evogene was able to translate our initial investment into an attractive venture opportunity."
Ofer Haviv, chief operating officer of Evogene, stated, "Our first private placement is clearly an important financial milestone in our development into a leading agricultural biotechnology company, and is also a vote of confidence, by our new investors, in our ability to address the growing needs of the plant biotechnology market. Having reached this milestone, we would like to thank Compugen for its past and continuing support as Evogene moves forward to the next stages of its development."
Published by Globes [online] - www.globes.co.il - on 06 January 2003